MedPath

Effects of unani formulation in wound healing

Phase 2
Conditions
Health Condition 1: L80-L99- Other disorders of the skin and subcutaneous tissue
Registration Number
CTRI/2024/02/063110
Lead Sponsor
Hakim Syed Ziaul Hasan Government Autonomous Unani Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 Adults 18 years or older of all sex having

drainable abscess less than or equal to 5cm in greater diameter

2 Adults having Corn of 3 to 7 mm in greater diameter.

Exclusion Criteria

Immunocompromising conditions

Clinically diagnosed Tubercular abscess

Severe anaemia

Uncontrolled HTN

HIV AIDS

Patients who used Immunosuppressive therapy

Carcinoma

Known allergy to either test drugs Marhame Raal and Qurse Asfar or control drugs Povidone Iodine and Penicillin group and beta lactam group antibiotics

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical complete wound healing <br/ ><br>Timepoint: Base line, 2nd day, 4th day and 10th day <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Discomfort on dressing change and Patient SatisfactionTimepoint: 2nd day and 4th day
© Copyright 2025. All Rights Reserved by MedPath